Chemoradiotherapy

Treatment that combines chemotherapy with radiotherapy.

Also Known As:

Concomitant Chemoradiotherapy; Concomitant Radiochemotherapy; Concurrent Radiochemotherapy; Radiochemotherapy; Synchronous Chemoradiotherapy; Chemoradiotherapies; Chemoradiotherapies, Concomitant; Chemoradiotherapies, Concurrent; Chemoradiotherapies, Synchronous; Chemoradiotherapy, Concomitant; Chemoradiotherapy, Concurrent; Chemoradiotherapy, Synchronous; Concomitant Chemoradiotherapies; Concomitant Radiochemotherapies; Concurrent Chemoradiotherapies; Concurrent Radiochemotherapies; Radiochemotherapies; Radiochemotherapies, Concomitant; Radiochemotherapies, Concurrent; Radiochemotherapy, Concomitant; Radiochemotherapy, Concurrent; Synchronous Chemoradiotherapies; Concurrent Chemoradiotherapy

Networked: 17841 relevant articles (1538 outcomes, 3851 trials/studies)

Relationship Network

Therapy Context: Research Results

Therapeutics: 1190486

Experts

1.	Rödel, Claus: 99 articles (03/2024 - 01/2002)
2.	Fietkau, Rainer: 82 articles (11/2023 - 11/2002)
3.	Lim, Seok-Byung: 68 articles (10/2023 - 04/2005)
4.	Kim, Dae Yong: 68 articles (07/2023 - 04/2005)
5.	Ma, Jun: 66 articles (03/2024 - 02/2004)
6.	Belka, Claus: 64 articles (11/2023 - 12/2007)
7.	Kim, Jong Hoon: 60 articles (06/2023 - 06/2002)
8.	Yu, Jinming: 58 articles (01/2024 - 10/2008)
9.	Kim, Jin Cheon: 58 articles (10/2023 - 03/2007)
10.	Komaki, Ritsuko: 58 articles (01/2022 - 07/2003)

Related Diseases

1.	Neoplasms (Cancer) 05/01/2023 - "In the event where the tumor is in operable concurrent chemoradiotherapy is regarded as the best treatment modality. " 10/01/2021 - "Background Treatment with definitive chemoradiotherapy (CRT) is the best option for patients with locally advanced esophageal tumors considered unresectable or for patients without clinical conditions to undergo surgical treatment. " 09/15/2020 - "Therefore the question remains whether neoadjuvant chemotherapy or neoadjuvant radiochemotherapy is eliciting the best results in patients with GEJ cancer. " 01/01/2019 - "Chemoradiotherapy (CRT) remains one of the most common cancer treatment modalities, and recent data suggest that CRT is maximally effective when there is generation of an anti-tumoral immune response. " 01/01/2016 - "We aimed to evaluate the prognostic factors and efficacy of treatment modalities for patients with temporal bone cancer, and to determine if definitive chemoradiotherapy (CRT) for advanced-stage disease can provide a substitute for highly invasive surgeries. "
2.	Rectal Neoplasms (Rectal Cancer) 09/01/2011 - "To date, no suitable prognostic markers could be used to identify rectal cancer patients who are most likely to experience a good outcome after preoperative chemoradiotherapy. " 04/01/2020 - "The aim of this study is to develop a nomogram for prediction of pathologic complete remission (pCR) after preoperative chemoradiotherapy (CRT) for rectal cancer. " 05/01/2021 - "Although preoperative chemoradiotherapy for patients with locally advanced rectal cancer using the S-1 + oxaliplatin + bevacizumab regimen did not achieve the expected pathological complete response rate, this regimen led to an improved clinical response rate." 05/01/2019 - "In the locally advanced stage, the prognosis of rectal cancer was improved by preoperative chemoradiotherapy and radical surgery including complete total mesorectal excision. " 03/01/2019 - "Treatment of rectal cancer has been vastly improved by advances in surgery and radiochemotherapy but remains an important cause of morbidity and mortality worldwide. "
3.	Esophageal Neoplasms (Esophageal Cancer) 09/01/2020 - "Neoadjuvant radiochemotherapy (RCTH) is proven to be highly effective in the treatment of esophageal cancer (EC). " 01/01/2007 - "Recent advances in multimodality chemoradiotherapy and surgery has improved survival in patients with loco-regional disease, but most patients with advanced stage esophageal cancer have a poor prognosis. " 01/01/2021 - "This study aimed to evaluate the efficacy of radical radiotherapy and assess prognostic factors in metachronous oligometastatic esophageal cancer (MOEC) patients after initial treatment with curative-intent surgery and/or chemoradiotherapy. " 08/01/2022 - "Concurrent single-agent S-1 chemoradiotherapy may induce complete remission of stage IIIB esophageal cancer and is a possible alternative for older patients or those with multiple comorbidities." 08/01/2022 - "Complete remission after concurrent single-agent S-1 chemoradiotherapy for stage IIIB esophageal cancer: an autopsy case report."
4.	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/31/2023 - "There is no consensus on the most reliable procedure to determine remission of cervical cancer after chemoradiotherapy (CRT). " 11/01/1999 - "However, this February NCI suggested concomitant chemoradiotherapy was effective for improving the survival rates of most cervical cancer patients. " 10/01/2023 - "This case shows that using checkpoint inhibitors with chemoradiotherapy can be a very effective treatment for cervical cancer that has spread to other parts of the body." 04/07/2022 - "Toxicity during chemoradiotherapy (CRT) in cervical cancer patients might limit the chances of receiving an optimal treatment and to be cured. " 10/01/2021 - "Surgery followed by concurrent radiochemotherapy was a feasible and effective treatment with acceptable complications for locally recurrent cervical cancer, which markedly improved the survival of pelvic sidewall recurrence."
5.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/23/2023 - "4) neoadjuvant/adjuvant therapy: marked improvement in the prognosis of non-small cell lung cancer (NSCLC) patients receiving neoadjuvant immunotherapy are reviewed; more options for consolidation immunotherapy after radiochemotherapy have also emerged. " 07/18/2023 - "4) neoadjuvant/adjuvant therapy: marked improvement in the prognosis of non-small cell lung cancer (NSCLC) patients receiving neoadjuvant immunotherapy are reviewed; more options for consolidation immunotherapy after radiochemotherapy have also emerged. " 05/01/2015 - "In a phase III trial of patients with unresectable, locally advanced, stage III non-small-cell lung cancer (NSCLC) with a poor prognosis, palliative concurrent chemoradiotherapy (CRT) provided a significantly better outcome than chemotherapy alone, except among performance status (PS) 2 patients. " 12/01/2009 - "Concurrent chemoradiotherapy is standard of care in stage III non-small-cell lung cancer, although surgery may be beneficial in selected patients in whom induction therapy has achieved 'down-staging' of mediastinal nodal disease. " 01/01/2008 - "Multimodality treatment, including surgery, is beneficial for patients with unresectable locally advanced non-small cell lung cancer who respond to chemotherapy or chemoradiotherapy, especially those patients with ycN0 or pN0."

Related Drugs and Biologics

1.	Cisplatin (Platino)
2.	Fluorouracil (Carac)
3.	Docetaxel (Taxotere)
4.	durvalumab
5.	Gemcitabine
6.	Carboplatin (JM8)
7.	Paclitaxel (Taxol)
8.	Platinum
9.	Temozolomide (Temodar)
10.	Cetuximab (Erbitux)

Related Therapies and Procedures

1.	Radiotherapy
2.	Drug Therapy (Chemotherapy)
3.	Therapeutics
4.	Induction Chemotherapy
5.	Neoadjuvant Therapy